FDA approves first m RNA-based flu vaccine
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
24 sources checked · Left, Center, and Right included · 7m ago
NBC News - US News reaches for "victory" where Washington Examiner stays flat.

DIFFERENT SPIN
HOW EACH SIDE WORDED IT
As of August 6, 2026 at 1:03 PM, this is how Optics News reads the wording differences in this story.
24 sources across Left, Center, and Right all describe the same event.
58/99 — meaningful wording shift across the spectrum.
WHAT EACH SIDE EMPHASIZED
The Independent · Center-left · News report
WISN12 Milwaukee (Hearst) · Center · News report
Washington Examiner · Center-right · News report
SEE THE HEADLINES
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The Food and Drug Administration on Wednesday approved the first m RNA-based influenza vaccine, marking a milestone for the technology, which was first widely used during the COVID-19 pande...
WASHINGTON (AP) — The Food and Drug Administration has approved a new kind of flu vaccine for older people, the…
The Food and Drug Administration has approved a new flu vaccine for older people, the first made with the same m RNA technology that was key to ending the COVID-19 pandemic
The FDA has approved Moderna's flu vaccine for people aged 50 and older, marking the first approval of a messenger RNA-based vaccine for seasonal flu.
The Food and Drug Administration (FDA) late Wednesday approved the nation's first m RNA flu vaccine, manufactured by drugmaker Moderna.
The Food and Drug Administration (FDA) late Wednesday approved the nation's first m RNA flu vaccine, manufactured by drugmaker Moderna.
The agency approved the shot for two separate age groups: People age 50 to 64, and for 65 years and older.
A younger and higher-educated base were pivotal to Abdul El Sayed’s Senate Primary win, an analysis shows.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The Food and Drug Administration (FDA) late Wednesday approved the nation’s first m RNA flu vaccine, manufactured by drugmaker Moderna. The agency approved the shot for two separate age gro...
SOURCE MAP CHANGES
Aug 6, 10:39 AM: The Hill joined the source map.
Aug 6, 10:58 AM: WDSU New Orleans (Hearst) joined the source map.
Aug 6, 10:58 AM: WCVB Boston (Hearst) joined the source map.
Aug 6, 10:58 AM: WMUR9 (Hearst, Manchester NH) joined the source map.
Now: Wording Gap is 58/99 and story health is stable · 24 sources · all three buckets · comparable news format.